SU2C Innovative Research Grant: Probing EBV-LMP-1’s Transmembrane Activation Domain With Synthetic Peptide - Stand Up To Cancer

Blog

Posted October 9, 2019

SU2C Innovative Research Grant: Probing EBV-LMP-1’s Transmembrane Activation Domain With Synthetic Peptide

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.